Printer Friendly
The Free Library
5,669,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BioTrove and Blue Sky Biotech Introduce Unique Screening Solution Portfolio for Challenging Drug Targets.


WOBURN, Mass. -- BioTrove, Inc. and Blue Sky Biotech, Inc. announce a collaborative effort to provide a unique service solution, utilizing mass spectrometry-based high-throughput screening High-throughput screening (HTS), is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry. Purpose and method  assays on previously unscreenable drug targets. Blue Sky will provide pharma-grade proteins that pharmaceutical companies can quickly screen against their entire small molecule libraries. BioTrove will utilize its proprietary RapidFire(TM) screening technology that has successfully screened millions of compounds.

The collaboration will initially focus on high value targets in key therapeutic areas such as metabolic disorders and oncology. Specific examples of current projects include acyl-coenzyme A diacylglycerol acyltransferase (DGAT), 11 beta-hydroxysteroid dehydrogenase dehydrogenase /de·hy·dro·gen·ase/ (de-hi´dro-jen-as?) an enzyme that catalyzes the transfer of hydrogen or electrons from a donor, oxidizing it, to an acceptor, reducing it.

de·hy·dro·gen·ase
n.
 (11 beta-HSD), desaturases, and a family of histone deacetylases (HDACs).

BioTrove's RapidFire(TM) screening technology combines innovative micro-fluidics and high-throughput mass spectrometry mass spectrometry
 or mass spectroscopy

Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields.
 to identify lead compounds against a wide variety of challenging enzymatic targets. High throughput assays are rapidly developed and utilize the direct detection of native, label-free substrate and product. This allows screening of a wide variety of targets, including many that are difficult or impossible to screen with conventional approaches.

"We are excited to offer the pharmaceutical community a complete HTS HTS Heights
HTS Harmonized Tariff System
HTS High Throughput Screening (biomolecular assay screening)
HTS High-Throughput Screening (Pharmaceutical Industry)
HTS Harmonized Tariff Schedule
 solution around a suite of enzymatic targets that clearly have high thereapeutic and economic value. This relationship will expand our growing list of pharmaceutical business partners" said Can "Jon" Ozbal, director of RapidFire technologies at BioTrove.

Blue Sky Biotech, Inc. is an integrated service provider of "Gene to Screen" discovery biologicals. Currently, Blue Sky offers four linked laboratory service segments: Molecular Biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller , Tissue Culture/Fermentation, Protein Sciences, and Cell Biology Cell biology

The study of the activities, functions, properties, and structures of cells. Cells were discovered in the middle of the seventeenth century after the microscope was invented.
. This pre-clinical contract service bundle offers research-based drug discovery clients a convenient source of pharma-grade research tools.

"The unique combination of RapidFire(TM) HTS technology and Blue Sky Biotech's reagent provision expertise will provide our mutual customers with an immense competitive advantage in drug-discovery," said Paul Wengender, president of Blue Sky Biotech.

For more information, or to discuss our first fully validated assay system (acetyl-coenzyme A carboxylase carboxylase /car·box·y·lase/ (kahr-bok´si-las) an enzyme that catalyzes the removal of carbon dioxide from the carboxyl group of alpha amino keto acids.

car·box·yl·ase
n.
; ACC See adaptive cruise control. ), please visit us at Booth #100 at ScreenTech, March 22nd - 24th, in San Diego, CA.

About BioTrove, Inc.

BioTrove offers two innovative platform technologies that dramatically increase the throughput of pharmaceutical screening and SNP SNP Scottish National Party

Noun 1. SNP - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily
 genotyping.

RapidFire(TM) Lead Discovery enables drug developers to analyze samples using ultra high-throughput mass spectrometry in less than 8 seconds per sample. This technology enables difficult targets (lipids, fatty acids, phospholipids, steroids, and prostaglandins Prostaglandins
Prostaglandins are produced by the body and are responsible for inflammation features, such as swelling, pain, stiffness, redness and warmth.
) to be tested using a high-throughput, native detection method.

The OpenArray(TM) platform enables genomics researchers to generate up to hundreds of thousands of data points per day. The flexible format of the OpenArray(TM) plate allows researchers to adjust to their changing needs in sample and assay numbers. Additionally, the nanoliter scale of this flexible system makes high-throughput genotyping economical.

About Blue Sky Biotech, Inc.

Blue Sky Biotech is a Contract Research Organization serving the research-based drug discovery community. Blue Sky produces high quality reagents using the latest state-of-the-art technologies. Blue Sky is located in Worcester, MA.

For more information, please visit www.biotrove.com or www.blueskybiotech.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 21, 2006
Words:497
Previous Article:SciQuest's Charles Ballaro Named to Supply and Demand Chain Executive's 2006 Pros to Know; Ballaro Honored for Leadership, Innovative Vision in...
Next Article:picoChip Expands Sales Network across Europe.(Company overview)
Topics:



Related Articles
Many happy returns: financial companies see a future with gay investors.(Money Guide)(Cover Story)
The challenges of data management in biotech: booming life sciences research has IT resources bursting at the seams. (Storage Networking).(Industry...
KINEXUS VALIDATES PLK1 AS CANCER DRUG TARGET.
BioTrove and Sitris Pharmaceuticals Expand RapidFire(TM) High Throughput Screening Relationship.
Cue Biotech, Inc. Enters Collaboration with Lundbeck to Discover Allosteric Modulators of G-Protein Coupled Receptors.
Investment and Business Trends Driving Biotechnology during the year 2005.
Elixir Pharmaceuticals and Siena Biotech S.p.A. Enter Agreement to Evaluate SIRT1 Inhibitors in Huntington's Disease.
Leading Australian Biotech CEOs to Showcase Cutting-Edge Science at New York City Conference.
Leading Australian Biotech CEOs to Showcase Cutting-Edge Science at Bay Area Conference.
Innovations in Proteomic Sample Prep: Partnership Between Digilab BioVisioN GmbH and GenWay Biotech, Inc.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles